MariMed Inc.MariMed Inc.MariMed Inc.

MariMed Inc.

No trades
See on Supercharts
Market capitalization
‪101.29 M‬USD
−0.0430USD
‪−16.03 M‬USD
‪148.60 M‬USD
‪313.28 M‬
Beta (1Y)
0.95

About MariMed Inc.

CEO
Jon R. Levine
Headquarters
Norwood
Employees (FY)
721
Founded
2011
FIGI
BBG002S0QJN9
MariMed, Inc. engages in direct owning of cannabis licenses and management of seed-to-sale operations. It focuses on the development, operation, management, and optimization of facilities for the cultivation, production, and dispensing of medicinal and recreational cannabis and cannabis-infused products. The company was founded by Robert N. Fireman and Jon Levine on January 25, 2011 and is headquartered in Norwood, MA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of MRMD is 0.2556 USD — it has decreased by 5.33% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange MariMed Inc. stocks are traded under the ticker MRMD.
MariMed Inc. is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
MRMD stock is 7.57% volatile and has beta coefficient of 0.95. Check out the list of the most volatile stocks — is MariMed Inc. there?
MariMed Inc. revenue for the last quarter amounts to ‪38.80 M‬ USD despite the estimated figure of ‪39.24 M‬ USD. In the next quarter revenue is expected to reach ‪39.17 M‬ USD.
Yes, you can track MariMed Inc. financials in yearly and quarterly reports right on TradingView.
MRMD stock has risen by 2.24% compared to the previous week, the month change is a 0.24% rise, over the last year MariMed Inc. has showed a 34.46% decrease.
MRMD net income for the last quarter is ‪−10.17 M‬ USD, while the quarter before that showed ‪−4.26 M‬ USD of net income which accounts for −138.76% change. Track more MariMed Inc. financial stats to get the full picture.
Today MariMed Inc. has the market capitalization of ‪95.88 M‬, it has increased by 6.64% over the last week.
No, MRMD doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, MRMD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MariMed Inc. stock right from TradingView charts — choose your broker and connect to your account.
MRMD reached its all-time high on Oct 8, 2018 with the price of 5.8000 USD, and its all-time low was 0.0250 USD and was reached on Nov 21, 2012.
See other stocks reaching their highest and lowest prices.
As of Apr 23, 2024, the company has 721.00 employees. See our rating of the largest employees — is MariMed Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MariMed Inc. technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MariMed Inc. stock shows the sell signal. See more of MariMed Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on MariMed Inc. future price: according to them, MRMD price has a max estimate of 0.50 USD and a min estimate of 0.50 USD. Read a more detailed MariMed Inc. forecast: see what analysts think of MariMed Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MariMed Inc. EBITDA is ‪23.65 M‬ USD, and current EBITDA margin is 15.92%. See more stats in MariMed Inc. financial statements.